Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,121
  • Shares Outstanding, K 581
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,500 K
  • EBIT $ -6 M
  • EBITDA $ -9 M
  • 60-Month Beta 2.46
  • Price/Sales 6.57
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.35 +9.10%
on 10/24/24
4.11 -10.98%
on 10/21/24
+0.01 (+0.41%)
since 10/04/24
3-Month
3.30 +10.76%
on 09/20/24
4.76 -23.21%
on 09/18/24
+0.05 (+1.29%)
since 08/05/24
52-Week
2.23 +63.90%
on 06/10/24
8.92 -59.02%
on 07/15/24
-3.05 (-45.45%)
since 11/03/23

Most Recent Stories

More News
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) will showcase its inflammation and immunology (“I&I”) product pipeline and contract development and manufacturing (“CDMO”) services at the BIO-Europe 2024...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Schedules Virtual Panel Discussion

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) CEO Featured on Latest Episode of BioMedWire Podcast

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Q2 2024 Financial Results

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Receives PEI Feedback Regarding Anti-IL-17 NanoAb

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Receives Updated LOI from European Investment Bank

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing CDMO services through its Scinai Bioservices...

SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Releases Q1 2024 Financial Reports

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

AMD : 141.08 (+0.26%)
SCNI : 3.66 (+0.14%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Releases FY 2023 Financial Results

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and...

SCNI : 3.66 (+0.14%)

Business Summary

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 3.82
2nd Resistance Point 3.75
1st Resistance Point 3.70
Last Price 3.66
1st Support Level 3.58
2nd Support Level 3.51
3rd Support Level 3.46

See More

52-Week High 8.92
Fibonacci 61.8% 6.36
Fibonacci 50% 5.57
Fibonacci 38.2% 4.79
Last Price 3.66
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar